|
C17ORF71 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.0076999951435E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.16090000010527E-07 |
| Normal-vs-Stage2 |
1.268250E-02 |
| Normal-vs-Stage3 |
2.85860000004412E-07 |
| Normal-vs-Stage4 |
5.66350000230642E-08 |
| Stage1-vs-Stage2 |
2.265000E-01 |
| Stage1-vs-Stage3 |
2.718000E-01 |
| Stage1-vs-Stage4 |
3.016200E-02 |
| Stage2-vs-Stage3 |
7.507900E-02 |
| Stage2-vs-Stage4 |
1.156210E-02 |
| Stage3-vs-Stage4 |
2.092400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.08010000335435E-08 |
| Normal-vs-AfricanAmerican |
8.559100E-03 |
| Normal-vs-Asian |
6.259300E-03 |
| Caucasian-vs-AfricanAmerican |
4.806000E-01 |
| Caucasian-vs-Asian |
1.934380E-01 |
| AfricanAmerican-vs-Asian |
8.108200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75840000338212E-08 |
| Normal-vs-Female |
3.26440000031347E-07 |
| Male-vs-Female |
8.101600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.98939999998638E-06 |
| Normal-vs-Age(41-60Yrs) |
9.30530000053942E-07 |
| Normal-vs-Age(61-80Yrs) |
1.87429999998212E-06 |
| Normal-vs-Age(81-100Yrs) |
1.793870E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.799600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.169400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.030000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.826200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.301400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.980200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.179250E-01 |
| Classical-VS-Follicular |
6.214000E-02 |
| Classical-VS-Other |
9.402200E-02 |
| Classical-VS-Normal |
1.59239999997229E-06 |
| Tall-VS-Follicular |
7.574800E-01 |
| Tall-VS-Other |
3.712800E-01 |
| Tall-VS-Normal |
1.64507000000036E-05 |
| Follicular-VS-Other |
3.672000E-01 |
| Follicular-VS-Normal |
1.92499999995821E-06 |
| Other-VS-Normal |
4.659600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.1374999999455E-06 |
| Normal-vs-N1 |
1.25440000053878E-07 |
| N0-vs-N1 |
1.480150E-02 |
|
|
